Loading provider…
Loading provider…
Radiation Oncology Physician in Lexington, KY
NPI: 1164685012Primary Practice Location
BAPTIST HEALTH LEXINGTON
1740 Nicholasville Rd, Lexington, KY
Primary Employer
Radiation Oncology of Lexington, PSC
rolexington.com
HQ Phone
Get MD Jonathan's Phone Numberphone_androidMobile
Get MD Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKY State Medical License
KY State Medical License
2011 - 2026

American Board of Radiology
Radiation Oncology
University of Kentucky College of Medicine (Bowling Green)
Internship • Transitional Year
2007 - 2008
University Of Kentucky College Of Medicine
medicine.uky.edu
Medical School
Until 2007
Residency • Radiation Oncology
2008 - 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 85 | 100 |
| 2 | 77300Calculation of radiation therapy dose | 52 | 361 |
| 3 | 77014Ct scan guidance for insertion of radiation therapy fields | 52 | 406 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 46 | 46 |
| 5 | 77280Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 37 | 73 |
Authors: Feddock, Jonathan, Kudrimoti, Mahesh, Randall, Marc
Journal: Expert Rev Anticancer Ther
Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.
A feasibility study using TomoDirect for craniospinal irradiation
Authors: Ulrich W. Langner, J Molloy, John F. Gleason, Jonathan Feddock
Publication Date: 2013-09
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Etoposide, RADIATION: 3-Dimensional Conformal Radiation Therapy
Lead Sponsor: University of Kentucky
Intervention / Treatment: RADIATION: Paclitaxel+Initial Radiation+Boost
Lead Sponsor: GOG Foundation
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: Internal Radiation Therapy, RADIATION: 3-Dimensional Conformal Radiation Therapy